At PrecisionLife, we’re revealing a deeper understanding of disease biology through the combinatorial analysis of patient population datasets. We build high resolution patient stratifications to reveal how complex diseases manifest across patient sub-groups, to understand the drivers of their specific form of a disease, and explain why patients respond differently to certain treatments.
We’re developing a pipeline of disease studies across multiple chronic diseases including neurodegenerative, neuropsychiatric, cardiovascular, metabolic, respiratory and immunological disorders. Our studies generate validated novel targets in areas of unmet medical need matched to detailed patient stratification biomarkers, with lead molecules and deep insights into targets’ efficacy potential.